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Abstract: 
Metal chelating heteroaryl small molecules have found widespread use as building blocks 
for coordination-driven, self-assembling nanostructures. The metal chelating non-canonical 
amino acid ((2,2′-bipyridin-5yl)alanine (Bpy-Ala) could in principle be used to nucleate specific 
metalloprotein assemblies if introduced into proteins such that one assembly had much lower 
free energy than all alternatives.  Here we describe the use of the Rosetta computational 
methodology to design a self-assembling homo-trimeric protein with [Fe(Bpy-ala)3]
2+ complexes 
at the interface between monomers.  X-ray crystallographic analysis of the homotrimer showed 
that the design process had near atomic level accuracy:  the all atom RMSD between the design 
model and crystal structure for the residues at the protein interface is ~1.4 Å These results 
demonstrate that computational protein design together with genetically encoded non-canonical 
amino acids can be used to drive formation of precisely specified metal-mediated protein 
assemblies that could find use in a wide range of photo-physical applications. 
Significance: 
This article reports the computational design of a 3-fold symmetric, self-assembling protein 
homotrimer containing a highly stable non-canonical amino acid mediated metal complex within 
the protein interface. To achieve this result, recently developed protein-protein interface design 
methods were extended to include a metal chelating non-canonical amino acid containing a 
bipyridine functional group in the design process. Bipyridine metal complexes can give rise to 
photochemical properties that would be impossible to achieve with naturally occurring amino 
acids alone and suggests that the methods reported here could be used to generate novel 
photoactive proteins. 
Introduction: 
  
2,2’-bipyridine (Bpy) is one of the most widely used metal ligands in inorganic chemistry 
due to its redox stability, ability to form high affinity complexes of defined geometry with a 
variety of transition metals, and useful photochemical properties (1).  The highly specific 
geometries adopted by Bpy in metal complexes has led to its widespread use in generating 
coordination-driven self-assembling nanostructures (2).  For example, chemically synthesized, 
unstructured peptides containing the Bpy functional group as the side chain of an amino acid 
formed three helix bundles upon addition of metals (3, 4).  Recently, the ability to use Bpy in 
biological contexts was expanded through the addition of the non-canonical amino acid (NCAA) 
(2,2’-bipyridin-5yl)alanine, (Bpy-ala) to the genome of Escherichia coli (5).  Because Bpy forms 
very stable octahedral complexes with a number of biologically relevant divalent cations (e.g. 
Fe2+, Zn2+, Co2+, and Ni2+), an appropriately placed Bpy-ala residue could potentially be utilized 
to generate self-assembling proteins nucleated by [M(Bpy)3]
2+ complexes (where M is a divalent 
cation that forms an octahedral complex with Bpy).  Although we (6) and others (7, 8) have 
engineered proteins in which Bpy-ala served in structural or functional capacities, to our 
knowledge the possibility of using this NCAA to drive or stabilize the formation of a protein 
complex has not been explored. 
The strategy of using metal ions to mediate protein complex formation has its origins in 
naturally occurring proteins such as hexameric proinsulin in which complex formation is 
regulated by bound Ca2+ and Zn2+ ions (9).  Recently, the Tezcan (10) and Kuhlman (11) groups 
used rational and computational protein design methods, respectively, to engineer metal-
dependent protein-protein interactions using conserved di-histidine metal binding motifs from 
known metalloproteins.  In each case, structural analysis of the engineered protein complexes 
suggested that although metal dependent assembly had been achieved, the metal binding sites 
  
had not formed as desired (10, 11).  While notable successes, these studies highlight the 
difficulty in precisely stabilizing the conformations of multiple amino acid side chains at once.  
We reasoned that an appropriately placed, genetically encoded Bpy-ala residue could nucleate a 
3-fold symmetric, homo-trimeric metalloprotein while overcoming some of the difficulties faced 
in the previous studies. 
Here we report the use of the Rosetta computational protein design methodology (12) to 
engineer a homo-trimeric protein containing an octahedral [Fe(Bpy-ala)3]
2+ complex.  
Crystallographic analysis indicated that near atomic level accuracy between the design model 
and resulting protein was achieved in the vicinity of the protein-protein interface.  The methods 
developed in this study could be applied to the generation of novel protein therapeutics, protein 
based materials, and metalloproteins with useful optical or photochemical properties. 
Results 
Computational design strategy 
A previous study in which Bpy-ala was used to engineer a novel metal binding site in a 
protein scaffold highlighted important considerations for protein design efforts using this NCAA 
(6).  In a design in which the Bpy-ala residue was not well constrained by packing interactions, 
we observed the formation of a highly stable [Fe(Bpy-alaf)2(Bpy-alap)]
2+ complex (where Bpy-
alaf is the free amino acid in the cell, and Bpy-alap is NCAA which has been incorporated in the 
protein) within the E. coli expression host.  This observation was encouraging from the 
perspective that protein containing [Fe(Bpy-ala)3]
2+ complexes can be purified intact from E. 
coli, but also suggested that for the present application, mono- or dimeric forms of the desired 
trimeric protein could be kinetically trapped by free Bpy-ala within the cell.  Furthermore, even 
if a [Fe(Bpy-alap)3]
2+ complex is formed as desired, in the absence of a driving force other than 
  
the Bpy-ala complex formation, the subunit orientations in the resulting protein complexes 
would not likely be well defined. 
To address these concerns, our computational design approach sought to achieve two 
distinct goals: identification of sites of Bpy-ala incorporation in starting scaffolds that are 
compatible with trimer formation, and design of interactions between protein subunits to drive 
the formation of a particular trimeric orientation at the exclusion of others.  Our starting scaffold 
set consisted of a set of 9 de novo designed repeat proteins of known structure recently reported 
by our lab (13, 14).  Because they are constructed from many identical subunits, the sizes of 
repeat proteins can be easily scaled in a defined manner and the versatility in length afforded by 
repeat protein architectures could be useful for downstream applications.   
Potential sites of Bpy-ala incorporation within a given starting scaffold were first 
identified using Rosetta docking calculations (see supplemental information for full 
computational design methods). For each parent scaffold, 3 rotational and 1 translational degrees 
of freedom were sampled with a 2.5° covering radius to generate all possible 3-fold symmetric 
conformations in the context of polyalanine versions of the parent scaffolds.  Successfully 
docked proteins contained geometrically complementary interfaces without steric clashes 
between the protein backbones of adjacent subunits.   
We next searched for potential sites of octahedral [M(Bpy-ala)3]
2+ complex incorporation 
within these trimeric scaffolds.  Because previous results indicated that [Fe(Bpy-ala)3]
2+ 
complexes can form within E. coli expression hosts (6), we chose to design our trimeric proteins 
in the context of these complexes.  Octahedral Bpy complexes exist in two enantiomeric forms, 
 and  and geometric constraints for each isomer were extracted from the Cambridge 
Structural Database (CSD ID KICRAR), and used to generate a [Fe(Bpy-ala)3]
2+ complex with 
  
ideal geometries for further calculations (Fig. 1A).  All symmetry related C atoms in a given 
docked configuration were then computationally scanned for the ability to overlap with the Cs 
in - and -Bpy-ala complexes.  Placed Bpy-ala complexes were removed from further 
consideration if the C-C-C angle differed by more than 3° from the value of 116° observed in 
the crystal structure of a Bpy-ala containing protein (PDB ID 4iww). 
Docked trimer models containing a [Fe(Bpy-ala)3]
2+ complex (Fig. 1B) were then 
subjected to iterative rounds of RosettaDesign (15) to generate a low energy, well-packed 
interface between protein subunits (Fig. 1C).  These designs were then filtered on the shape 
complementarity (16) between protein interfaces and the change in solvent exposed surface area 
(SASA) upon dissociation of the protein complex. 
Initial Characterization of the Designed Proteins  
A total of seven designed proteins were generated through oligonucleotide mutagenesis 
of the parent scaffolds.  An amber stop codon (TAG) was substituted for the wild type codon at 
the desired site of Bpy-ala incorporation.  pET21b expression plasmids encoding the designed 
proteins were co-transformed with the pEVOL-BpyRS plasmid (Schultz laboratory, The Scripps 
Research Institute) into a BL21 (DE3) E. coli expression strain.  The pEVOL-BpyRS plasmid 
contains an orthogonal tRNA / aminoacyl tRNA synthetase pair that enzymatically acylates a 
tRNA containing an anti-codon loop specific to the amber codon with the Bpy-ala amino acid.  
Thus, full-length protein expression should only occur in the presence of the NCAA; in the 
absence of Bpy-ala in the expression medium the amber stop codon should terminate translation.  
Expression trials for each of the designed proteins were therefore carried out in the presence and 
absence of Bpy-ala.  Of the 7 designs tested, 6 showed full-length protein expression only in the 
presence of the Bpy-ala amino acid (Fig. S1), and were subjected to additional characterization. 
  
Tris-Bpy complexes containing metals including Zn2+, Ni2+, or Fe2+ have characteristic 
spectroscopic signatures in the UV and visible wavelength ranges.  Absorbance in the range of 
290-330 nm corresponds to — * transitions within the Bpy ligand, and is observed in 
complexes of Bpy with a number of biologically relevant metals (17).  [Fe(Bpy)3]
2+ complexes 
exhibit metal-ligand charge transfer (MLCT) which gives rise to characteristic absorption spectra 
in the visible wavelength range of 450-575 nm (18).  To examine whether or not Bpy-ala 
mediated complex formation had occurred, the absorbance of the designs was analyzed from 
230-600 nm after nickel affinity purification.  Two designed proteins (TRI_03 and TRI_05) 
showed absorbance in the range of 450-575 nm with max values of 490 and 525 nm, consistent 
with a [Fe(Bpy)3]
2+ complex (Fig. 2A and 2C) (18).  Both TRI_03 and TRI_05 had as their 
parent scaffolds de novo designed ankyrin like repeat proteins (PDB IDs 4gpm and 4hb5 
respectively) (13).  Purified designs were then subjected to analysis by size exclusion 
chromatography (SEC), and were observed to elute at volumes indicative of proteins slightly 
larger than expected for the trimeric complexes relative to standards of known molecular weight 
(Fig. 2B and 2D).  This discrepancy in apparent size could be due to the unusually large Stokes 
radii of the trimeric complexes (19).  Although both proteins formed some soluble aggregates 
(Fig. 2B and 2D), TRI_03 appeared to be more prone to aggregation than TRI_05.  Chiral  and 
 Bpy complexes give rise to characteristic circular dichroism (CD) signals in the near UV.  CD 
analysis of TRI_05 gave a spectrum characteristic of the  isomer (Fig. 2E) (18), which was 
consistent with the designed complex. 
To further characterize TRI_03 and TRI_05, the proteins were expressed and purified in 
large scale in preparation for crystallographic analysis.  TRI_03 was observed to precipitate at 
  
high protein concentration, likely due to its propensity to aggregate.  In contrast, TRI_05 was 
stable at high concentrations, and was subjected to crystallographic trials. 
Structural Characterization of TRI_05 
We solved the structure of TRI_05 to 2.2 Å resolution.  The designed trimeric topology 
of TRI_05 was observed in the crystal structure and electron density corresponding to a tris-
bipyridine metal complex was clearly visible at the trimeric interface (Figs. 3A and 3B).  The 
RMSD between the design model and the crystal structure is 1.4 Å for all atoms on the first two 
helices that participate directly in the interface.  When superimposed on the interface residues, 
global deviations between the design model and structure are observed in the C-terminal repeats, 
likely due to slight deviations in the vicinity of the designed interface that propagate into much 
larger differences in the remainder of the protein.  A global fit of all backbone atoms in the 
design to the structure gives an RMSD of 2.5 Å.  Very good agreement between the design 
model and the structure was observed for the side chains in the interface with the exception of 
Ile14, Leu38, and Met46.  Ile14 adopts different rotamers in the design model and the solved 
structure (Fig. 3C).  Larger deviations are observed for Leu38 and Met46, due to an 
unanticipated interaction between Met46 and Leu26 that forces Leu38 into a rotameric state not 
present in the design model. 
Transient Absorbance Analysis of TRI_05 
Femtosecond time resolved spectroscopic methods can be used to probe the 
photophysical properties of complexes such as [Fe(Bpy)3]
2+ (20).  Photoexcitation of such 
complexes in the MLCT domain results in the transfer of an electron from the metal ion to the 
ligands and the solvent environment can affect the evolution of the excited state (21).  Because 
TRI_05 represents the first example of a protein containing a [Fe(Bpy-ala)3]
2+ complex, we 
  
explored the possibility that the excited state dynamics would be altered by encapsulation of the 
complex within the protein environment.  We therefore carried out femtosecond time resolved 
absorption spectroscopy on both TRI_05 and the free [Fe(Bpy-ala)3]
2+ complex.  Excitation at 
440 nm results in a characteristic loss of absorbance (bleaching) in the MLCT range (450-700 
nm, Fig. 4A). Recovery of this bleach was used to determine excited state decay.  Overlays of 
the excited state decays measured at 530 nm (corresponding to the wavelength with largest A) 
of TRI_05 and the free [Fe(Bpy-ala)3]
2+ complex are essentially superimposable (Fig. 4B).  To 
more fully quantify any differences, mono-exponential fits of these data were carried out, and 
suggested lifetimes of 690 ps for TRI_05 and 610 ps for the free complex (Fig. S2).  These 
lifetimes are identical within error, and are in relatively good agreement with previously reported 
values of the excited state lifetime of [Fe(Bpy)3]
2+ complexes (810 ps, ref 19); the small 
difference between our values and the previously reported lifetimes could originate from 
differences in Bpy substitution or solvent composition.  One potential explanation for the 
similarity of our measured values for the excited state lifetimes of free [Fe(Bpy-ala)3]
2+ and 
TRI_05 is that the [Fe(Bpy-ala)3]
2+ complex is only partially buried within the protein interface, 
and is solvent accessible from at least one face (Fig. 3 A and B).  Additionally, the solvent-
sensitive excited-state lifetimes of complexes such as [Ru(Bpy)3]
2+ are orders of magnitude 
longer than the [Fe(Bpy)3]
2+
 complexes (in the range of 10-600 ns, ref. (20)). In contrast, the 
picosecond lifetimes of [Fe(Bpy-ala)3]
2+ complex in TRI_05 may simply be too short to report 
on the surrounding environment. 
Metal Dependence of the Complex 
TRI_05 was purified from the expression host in complex with Fe2+. In order to analyze 
the dependence of the protein complex the bound metal, we attempted to remove the metal from 
  
the protein by adding an excess of the potent chelator 1,10-phenanthroline (Phen), which has an 
affinity for Fe2+ ~4 orders of magnitude higher than Bpy (22). Incubation of TRI_05 with an 
excess of Phen at 25 °C did not result in rapid exchange of the two metal ligands. We reasoned 
that metal removal might be accelerated at increased temperatures, and thus examined the 
thermal stability of TRI_05 using CD analysis (Fig. S3A-D).  Although slight unfolding was 
observed with increasing temperatures (Fig. S3B), TRI_05 did not appear to fully denature up to 
95 °C (Fig. S3C).  Furthermore, the partial unfolding was found to be reversible upon cooling to 
room temperature (Fig. S3C).  TRI_05 was incubated with an excess of Phen for 1 hour at 65 °C, 
after which spectroscopic analysis indicated the presence of a [Fe(Phen)3]
2+ complex, with no 
discernable signal indicative of [Fe(Bpy)3]
2+ complex (Fig. S4 A and B).  TRI_05 was then again 
subjected to SEC to remove unbound Phen and the [Fe(Phen)3]
2+ complex.  Apo TRI_05 eluted 
from the SEC column at the same volume observed prior to metal removal (Fig. S4 C), 
suggesting the presence of Fe2+ was not required to maintain the trimeric complex.  Eluted 
TRI_05 was analyzed spectroscopically at high concentration and no signal in the range of 450-
575 nm was observed suggesting the bound Fe2+ had been removed (Fig. S4 D). The possibility 
existed that apo TRI_05 scavenged metal, most likely Zn2+ during the purification process. To 
examine this, we carried out inductively coupled plasma mass spectrometric (ICP-MS) analysis 
of purified TRI_05 before and after removal of Fe2+ with Phen (Table S1). Although very little 
Zn2+ was observed in the Fe2+ containing trimer, a 2:1 ratio of Zn2+ to Fe2+ was observed in the 
apo protein suggesting the protein may have bound to Zn2+ during the purification process. 
Interestingly, no absorbance was observed in the range of 290—330 nm in the apo protein (Fig. 
S4 D) which would have been indicative of Zn2+ bound to Bpy-ala.  
  
To further confirm that a bound metal ion was not required for complex formation, we 
co-transformed the plasmid encoding the TRI_05 gene with a plasmid containing a synthetase 
that suppresses the amber stop codon with tyrosine rather than Bipy-ala. This tyrosine containing 
protein was subjected to SEC analysis and was observed to elute at the same time as the metal 
containing TRI_05 suggesting the presence of bound metal is not required to maintain trimer 
formation (Fig. S4 E). Finally, we explored the possibility that apo TRI_05 associated in a 
concentration dependent manner. When apo TRI_05 was subjected to SEC at 750 µM, the 
protein eluted at a volume consistent with the previously observed trimer with a shoulder 
indicative of a higher order species. When diluted to 75 µM and 35 µM, apo TRI_05 eluted at 
volumes 1.4 and 2 mL later than the concentrated sample respectively (Fig. S4 F). This suggests 
that, in the absence of a bound metal ion, TRI_05 is capable of self-associating, but does so in a 
concentration dependent fashion. 
We then examined the ability to re-form the [Fe(Bpy-ala)3]
2+ complex through addition 
of Fe2+ to solutions of apo TRI_05. Ferrous ammonium sulfate was added to a final 
concentration of 20 µM to a solution of apo TRI_05 at 60 µM and incubated for 12 hours at 65 
°C for 1 hour. Spectroscopic analysis of the TRI_05 suggested that no re-metallation had 
occurred under these conditions. We hypothesized that this was due to formation of a metal free 
complex in which one or more Bipy-ala side chains were buried in the protein interface. We then 
diluted apo TRI_05 to a final concentration of 2.5 µM (below the concentration observed to elute 
as a monomer on SEC) and concentrated the protein in the presence of 10 µM ferrous 
ammonium sulfate via ultrafiltration. The concentrated protein had an absorbance spectrum 
consistent with the original TRI_05 (Fig. S4 G), and analysis by SEC suggested that the complex 
  
had partially reformed whereas apo TRI_05 subjected to the same conditions in the absence of 
Fe2+ remained a monomer (Fig. S4 H). 
Discussion 
From the perspective of design of functional metalloproteins, the use of the Bpy 
functional group in a biological context provides a number of advantages.  The Bpy ligand 
provides two pyridyl nitrogens in an orientation compatible with metal binding, and therefore has 
a higher inherent metal affinity than any naturally occurring amino acid.  Bpy is also neutral and 
non-polar and hence it should be compatible with protein interfaces comprised mostly of 
hydrophobic residues.  The energies of formation of octahedral complexes of Bpy with 
biologically relevant metals range from -18.0 kcal / mol for Zn2+ to -27.5 kcal / mol for Ni2+ 
(values calculated from affinities reported in (22)) rivaling those of the tightest known protein-
protein interactions (23).  However, one potential drawback to the use of Bpy-ala in this manner 
is that these energetically favorable complexes form very rapidly and do not readily exchange at 
neutral pH (24).  Thus, while genetically encoded Bpy-ala could potentially be used to nucleate a 
C-3 symmetric, heterotrimeric protein complex around a bound metal, the potential to kinetically 
trap the protein complex as a monomer or dimer with free Bpy-ala, or form complexes with 
unintended orientations must be avoided. 
We addressed these issues by using the Rosetta computational protein design 
methodology to identify sites of Bpy-ala incorporation in protein scaffolds of known structure 
that were sterically compatible with complex formation and to design novel protein-protein 
interfaces that provide an additional driving force for the formation of the desired complexes at 
the exclusion of other, undesired states.  Of the seven computationally designed proteins we 
characterized experimentally, two were observed to have spectroscopic signatures indicative of 
  
the formation of [Fe(Bpy-ala)3]
2+ complexes.  Determination of the structure of one of these 
designs, TRI_05, revealed a trimeric metalloprotein containing the desired [Fe(Bpy-ala)3]
2+ 
complex; high similarity between the solved structure and the design model was observed in the 
vicinity of the trimeric interface.  Removal of the bound Fe2+ ion from TRI_05 with the potent 
metal chelator 1,10-phenanthroline did not result in the dissolution of the trimeric protein 
complex into its component monomers (Fig. S4 C).  This result highlights the ability of 
computational protein interface design algorithms to engineer high affinity interfaces between 
proteins that can be used to drive the formation of complexes of desired orientations. 
The computational methods developed in the course of this study could be extended to 
generate other novel proteins with useful properties:  The use of other metals or metal chelating 
NCAAs (e.g.  (8-hydroxyquino-lin-3yl)alanine (25)) could result in the formation of 2-fold 
symmetric protein-protein complexes with similar stabilities.  The ability to site specifically 
place metal ions within the context of protein complexes could pave the way to the development 
of new biomaterials with useful properties.  Finally, we demonstrated the ability to remove the 
and re-introduce the bound iron suggesting the possibility of introducing photoactive metals such 
as Ru2+ or Os2+ in the future, thereby facilitating the development of proteins with photochemical 
properties not achievable using exclusively naturally occurring amino acids. 
Materials and Methods 
Generation and cloning of designed proteins 
Sequences of the designed proteins were backtranslated and optimized for expression in E. 
coli using DNAWorks (26).  DNAWorks also generates sets of overlapping oligonucleotides 
from which full-length genes can be generated through assembly PCR (26).  These 
oligonucleotides were ordered from Integrated DNA Technologies (Coralville, IA) and 
  
assembled through a two-step PCR reaction.  PCR assembled gene fragments were then cloned 
into a pET21 expression vector (Novogen) between NdeI and XhoI restriction sites.  Sequences 
of the full-length genes were confirmed by Sanger sequencing. 
Protein expression and purification 
Slightly different protocols were used for analytical and production scale protein 
expressions. Detailed descriptions of each of these methods can be found in the SI; a general 
protein expression and purification protocol follows.  Sequence confirmed pET21 expression 
plasmids were co-transformed with the pEVOL-BpyRS plasmid into chemically competent 
BL21(DE3) cells (Life Technologies) and were selected on LB-agar plates containing ampicillin 
and chloramphenicol antibiotics.  Colonies with resistance to both antibiotics were used to 
inoculate expression cultures in Terrific Broth (TB) supplemented with both antibiotics.  
Expression cultures were grown at 37 °C until an optical density at 600 nm (OD600) value of 
~0.75 was reached.  The temperature was dropped to 18 °C and the Bpy-ala NCAA was added to 
a final concentration of 150 µM.  Expression was induced through the addition of L-arabinose 
and isopropyl -D-1-thiogalactopyranoside to final concentrations of 0.02% and 1 mM 
respectively and growth was allowed to continue at 18 °C for 30 hours at which time cells were 
harvested via centrifugation. 
 Cell pellets were lysed via sonic dismembration and the lysates were clarified by 
centrifugation.  The designed proteins were then purified by immobilized metal ion affinity 
chromatography on Ni-NTA resin (Qiagen) followed by SEC analysis on a Superdex 75 column 
(G.E. Biosciences).  The SEC step served to further purify the protein and also indicated the size 
of the expressed proteins. 
Crystallization of TRI_05 
  
TRI_05 was dialyzed against 25 mM Tris buffer pH 8.0 containing 150 mM NaCl, and 
concentrated via centrifugal ultrafiltration to a final concentration of 12 mg / ml.  Concentrated 
TRI_05 was screened using the sparse matrix method (27) with a Phoenix Robot and the 
following crystallization screens:  Crystal Screen, SaltRx, PEG/Ion, Index and PEGRx (Hampton 
Research, Aliso Viejo, CA) and Berkeley Screen (Lawrence Berkeley National Laboratory). 
Crystals of TRI_05 were found in the Berkeley Screen condition consisting of 0.1 M Magnesium 
Chloride, 0.1 M Sodium Acetate trihydrate pH 4.5 and 30% Pentaerythritol propoxylate. TRI_05 
crystals were obtained after 5 days by the sitting-drop vapor-diffusion method with the drops 
consisting of a mixture of 0.2 μl of protein solution and 0.2 μl of reservoir solution. 
Metal removal from TRI_05 
TRI_05 at concentrations between 50 and 75 µM, and in buffer containing 50 mM Tris, 
pH 7.6 and 150 mM NaCl was directly mixed with 1,10-phenanthroline to give a final chelator 
concentration of 1 mM. The protein and 1,10-phenanthroline mixture was then incubated at 65 
°C for one hour. To separate TRI_05 from free 1,10-phenanthroline and the [Fe(Phen)3]
2+ 
complex generated during the incubation, the mixture was subjected to gel filtration immediately 
after the incubation was complete. 
Re-addition of Fe2+ to TRI_05 
 Apo TRI_05 was diluted to a concentration of 2.5 µM in buffer containing 50 mM Tris, 
pH 7.6 and 150 mM NaCl from which contaminating metals had been removed by treatment 
with Chelex 100 resin. Ferrous ammonium sulfate was added to the protein solution to a final 
concentration of 10 µM and the mixture was applied to a Vivaspin 20 centrifugal concentrator 
(Sartorius). The protein was concentrated via centrifugation at 4,500 x g to a final volume of 0.5 
mL and was immediately subjected to analysis by SEC. 
  
ICP-MS analysis of proteins 
 To prepare samples for ICP-MS analysis, TRI_05 bound to Fe2+ and apo TRI_05 were 
dialyzed extensively against 1.5 L of 50 mM Tris, pH 7.6, and 150 mM NaCl. In total, the buffer 
was changed 5 times. Prior to dialysis, beakers were soaked overnight in 2 mM EDTA in an 
effort to remove contaminating metals. Buffers were also treated with Chelex 100 (Biorad) resin 
to remove exogenous metals. Samples were digested for three hours in trace metal grade HNO3 
and H2O2 with heating. After drying, samples were further digested overnight in concentrated 
HNO3 and HCl, and again were dried. Dilute HNO3 was added to a final volume of 15 mL the 
samples were applied to the instrument. Analysis was carried out on an iCAP Q quadrupole 
Electron X-series ICP-MS instrument (Thermo) in kinetic energy discrimination mode.  
X-ray diffraction collection and structural solution of TRI_05 
 X-ray diffraction data were obtained at the Advanced Light Source on beamlines 8.21 at 
wavelength 1.0 Å, and the initial data were processed with HKL2000 (28).  Phase information 
was obtained with molecular replacement using PHASER (29); a single chain of the TRI_05 
design in which all side chains were truncated at C was used as a search model.  Side chains 
were modeled using AutoBuild (30) using the sequence of the designed protein in which Bpy-ala 
was mutated to alanine.  Bpy-ala was substituted for alanine in the AutoBuild generated model 
using PyMol (31).  The model containing Bpy-ala was used as an input for a round of Rosetta-
Phenix refinement (32), after which iterative rounds of structural refinement (including addition 
of water molecules) were carried out with PHENIX (33). 
Transient Absorption Studies 
For transient absorption (TA) studies, 50 femtosecond laser pulses were generated by a 
Libra Ti:Sapphire laser system (Coherent). Approximately 75% (3 W) of the Ti:Sapphire output 
was used to pump an OPerA Solo Optical Parametric Amplifier (Coherent) to generate 440 nm 
  
excitation pulses, while the remainder (1 W) was reserved for visible probe generation. The 
excitation and probe beams were directed into a Helios TA spectrometer (Ultrafast Systems), 
where broadband, visible probe light was generated at a sapphire plate. TA spectra were 
collected in random order at 300 log-spaced time delays over the interval of ~2 ps to 5 ns; 
spectra at each time point were averaged over three scans. Data were processed with Surface 
Explorer software (Ultrafast Systems), and plotted and fit to single exponential decays using 
Matlab 2014b curve fitting software (MathWorks).  Spectra of TRI_05 and [Fe(Bpy-ala)3]
2+ 
were collected at concentrations of 100 µM in 30 mM Tris (pH 8.0) and 150 mM NaCl in quartz 
cuvettes.  An attempt was made to degas the TRI_05 sample, but resulted in precipitation of the 
protein.  TRI_05 spectra were therefore collected in cuvettes open to air.  Degasing of the 
[Fe(Bpy-ala)3]
2+ complex was possible, and the effect of oxygen on the recorded spectra was 
examined.  A [Fe(Bpy-ala)3]
2+ sample was degased prior to analysis via repeated rounds of 
evacuation of a stoppered cuvette followed by backfilling with N2.  Data collected in the 
presence and absence of air were indistinguishable from one another (Fig. S5). 
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Figures and Legends: 
 
Fig. 1. An overview of the computational design methods. (A) Octahedral [Fe(Bpy-ala)3]
2+ 
complexes (yellow sticks,  and  isomers) were generated from small molecule crystal 
structures and used as inputs for a docking algorithm that identified sites of incorporation in 
  
repeat protein scaffolds (gray cartoons) compatible with a 3-fold symmetric protein complexes. 
(B) Successfully docked trimers (multi-colored cartoons) were compatible with the geometries 
set by [Fe(Bpy-ala)3]
2+ complexes, and contained no steric clashes between protein subunits.  (C) 
Computational interface design methods were used to engineer highly complementary surfaces 
between trimer subunits (light blue sticks) to drive the formation of a protein complex with a 
desired 3-fold symmetric orientation. 
 
 
 
 
 
 
  
 
Fig. 2.  Experimental characterization of designs TRI_03 and TRI_05. Spectroscopic 
characterization of TRI_03 (A) and TRI_05 (C) and [Fe(Bpy-ala)3]2+ (E) in the range of 230—
650 nm is shown.  The MLCT regions of these spectra are enlarged in the insets.  SEC 
chromatograms of TRI_03 (B) and TRI_05 (D) are shown (solid lines) overlaid with traces of the 
monomeric parent scaffolds of TRI_03 and TRI_05 (PDB IDs 4gpm and 4hb5 respectively, 
dashed lines).  Soluble aggregates are observed for each protein at the column void volume of ~8 
  
mL.  Near UV circular dichroism analysis of TRI_05 (F) gave a spectrum consistent with the 
 isomer of a [Fe(Bpy)3]2+ complex. 
 
 
 
 
 
 
  
 
Fig. 3.  X-ray crystallographic analysis of TRI_05.  Electron density in the vicinity of the 
[Fe(Bpy-ala)3]
2+ complex of TRI_05 is shown in (A) and (B) contoured to 1.5 .  (C) An overlay 
of the design model (white) with the solved structure (blue) is shown in the vicinity of the 
designed interface.  All designed residues in the interface are depicted as sticks.  Residues whose 
side chains deviated from the designed conformation are labeled. 
 
 
  
 
Fig. 4. Transient absorbance analysis of TRI_05.  (A) Bleaching of TRI_05 MLCT absorbance at 
7 distinct time delays after excitation at 440 nm.  (B) Excited state lifetime of TRI_05 (red line) 
and [Fe(Bpy-ala)3]
2+ (blue line) complexes after excitation at 440 nm.  Absorbance 
measurements were obtained at 530 nm.  
 
 
 
 
 
 
 
 
 
 
 
 
